Alimera Sciences to Report Second Quarter 2021 Financial Results on Friday, August 13, 2021, and Provide Corporate Update

Rhea-AI Summary

Alimera Sciences, Inc. (ALIM) announces a conference call on August 13, 2021, at 9:00 AM ET to discuss its Q2 2021 financial results and corporate developments. This call follows the release of financial results before market open on the same day. Participants are encouraged to pre-register for the call, with dial-in options available for those unable to register online.

The company specializes in developing prescription ophthalmic pharmaceuticals, focusing on retinal diseases that impact many aging individuals.

Conference Call to be held Friday, August 13, 2021, at 9:00 am Eastern Time

ATLANTA, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera) a global pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals for the treatment of retinal diseases, announces today that it will report second quarter 2021 financial results on Friday, August 13, 2021, prior to the market open.

Management will host a conference call at 9:00 AM ET on Friday, August 13, 2021, to review financial results and provide an update on corporate developments. Following management’s formal remarks, there will be a question-and-answer session.

Participants are asked to pre-register for the call.

Please note that registered participants will receive their dial-in number upon registration and will dial directly into the call without delay. Those without Internet access or who are unable to pre-register may dial in by calling 1-844-839-2190 (domestic) or 1-412-717-9583 (international). All callers should dial in approximately 10 minutes prior to the scheduled start time and ask to be joined into the Alimera Sciences call.

The conference call will also be available through a live webcast, which is also available through the company’s website.

A webcast replay of the call will be available approximately one hour after the end of the call through November 12, 2021. The webcast replay can be accessed through the above links or by calling 1-877-344-7529 (domestic) or 1-412-317-0088 (international) and using access code 10158209. The telephonic replay will be available until August 27, 2021.

About Alimera Sciences, Inc.
Alimera Sciences is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and affect millions of people in our aging populations. For more information, please visit www.alimerasciences.com.

For press inquiries:			For investor inquiries:
Jules Abraham			Scott Gordon
for Alimera Sciences			for Alimera Sciences
917-885-7378			scottg@coreir.com
julesa@coreir.com

FAQ

When will Alimera Sciences report its Q2 2021 financial results?

Alimera Sciences will report its Q2 2021 financial results on August 13, 2021, prior to market open.

What time is the Alimera Sciences conference call?

The conference call for Alimera Sciences is scheduled for 9:00 AM ET on August 13, 2021.

How can I participate in the Alimera Sciences conference call?

Participants can pre-register for the call online or dial in using the provided numbers: 1-844-839-2190 (domestic) or 1-412-717-9583 (international).

Will there be a replay of the Alimera Sciences conference call?

Yes, a webcast replay of the call will be available approximately one hour after the call ends and can be accessed until November 12, 2021.